TPM3 and acute myeloid leukemia: Interestingly, an EN fusion found within a cell culture model of APML, [95] a subtype of AML, was hypersensitive to AZ-23, a selective NTRK inhibitor that has been previously validated in a Trk-expressing xenograft model of neuroblastoma [106].